Prognostic significance of interleukin-17 in solid tumors: a meta-analysis

被引:1
|
作者
Zeng, Yunhui [1 ]
Zhang, Qiongwen [1 ,2 ,3 ]
Wang, Hong [1 ]
Lu, Minxun [1 ]
Kong, Hongyu [1 ]
Zhang, Yingyi [1 ]
Shi, Huashan [1 ,2 ,3 ]
机构
[1] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Med Sch, West China Hosp, Ctr Canc, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Med Sch, West China Hosp, Dept Head & Neck Oncol, Chengdu 610041, Sichuan, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2015年 / 8卷 / 07期
关键词
Interleukin-17; solid tumor; prognosis; meta-analysis; SQUAMOUS-CELL CARCINOMA; IL-17-PRODUCING T-CELLS; TH17; CELLS; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; PROMOTES ANGIOGENESIS; CLINICAL-RELEVANCE; PANCREATIC-CANCER; SUPPRESSOR-CELLS; IL-17; EXPRESSION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The prognostic significance of intratumoral and peripheral interleukin-17 (IL-17) in tumors has been studied worldwide during these years, providing un-uniformed conclusions. Methods: We conducted a meta-analysis of published literatures that evaluated the correlation between IL-17 and clinical staging, overall survival (OS) and/or disease free survival (DFS). Results: A total of 28 studies enrolling 2902 patients were included. For the overall population, a high expression of IL-17 was found significantly correlated with worse DFS (HR = 1.59, 95% CI: 1.24-2.03) in patients with solid tumors. For gastrointestinal tumors, patients with IL-17 high seemed to have worse OS (HR = 1.85, 95% CI: 1.24-2.75) and DFS (HR = 2.41, 95% CI: 1.98-2.92). Sub-group meta-analysis revealed that IL-17 indicated late clinical staging in non-small cell lung cancer (NSCLC) patients (HR = 2.33, 95% CI: 1.25-4.32), on the other hand, early clinical staging in patients with esophageal squamous carcinoma (HR = 0.63, 95% CI: 0.42-0.94). Negative impacts of IL-17 on OS were shown in patients with hepatocellular carcinoma (HCC) (HR = 1.87, 95% CI: 1.23-2.84) or NSCLC (HR = 1.55, 95% CI: 1.02-2.35). However, positive impacts on OS were provided in patients with esophageal squamous carcinoma (HR = 0.65, 95% CI: 0.50-0.84). Besides, a high expression of IL-17 predicted better DFS in ovarian cancer patients (HR = 0.33, 95% CI: 0.11-1.00). Conclusions: Our meta-analysis revealed that IL-17 might correlate with poor OS and DFS in gastrointestinal tumors. Specifically, IL-17 was a detrimental factor for HCC and NSCLC patients, whereas a beneficial factor for patients with esophageal squamous carcinoma and ovarian cancer.
引用
收藏
页码:10515 / 10536
页数:22
相关论文
共 50 条
  • [41] Potential role of INTERLEUKIN-17 in the pathogenesis of oral lichen planus: a systematic review with META-analysis
    Husein-ElAhmed, H.
    Steinhoff, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (10) : 1735 - 1744
  • [42] Efficacy of interleukin-17 inhibitors on radiographic progression in psoriatic arthritis: A systematic review and meta-analysis
    Jiang, Han-Lei
    Du, Yu
    Tong, Qiang
    Dai, Sheng-Ming
    CHINESE MEDICAL JOURNAL, 2024, 137 (04) : 473 - 475
  • [43] Efficacy of interleukin-17 inhibitors on radiographic progression in psoriatic arthritis: A systematic review and meta-analysis
    Jiang Han-Lei
    Du Yu
    Tong Qiang
    Dai Sheng-Ming
    中华医学杂志英文版, 2024, 137 (04)
  • [44] Serum levels of interleukin-17 and 23 in patients with alopecia areata: a systematic review and meta-analysis
    Hua-Ching Chang
    Ming-Hsiu Lin
    Hsiou-Hsin Tsai
    European Journal of Dermatology, 2020, 30 : 200 - 201
  • [45] Prognostic significance of microRNA-101 in solid tumor: A meta-analysis
    Ma, Xianxiong
    Bai, Jie
    Xie, Gengchen
    Liu, Yulin
    Shuai, Xiaoming
    Tao, Kaixiong
    PLOS ONE, 2017, 12 (07):
  • [46] Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis
    Xiao, Kunmin
    Xiao, Kunlin
    Li, Kexin
    Xue, Peng
    Zhu, Shijie
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [47] Prognostic value of STC1 in solid tumors: a meta-analysis
    Li, Rongqi
    Liu, Rongqiang
    Wu, Shinan
    Zheng, Shiyang
    Ye, Lei
    Shao, Yi
    BIOMARKERS IN MEDICINE, 2022, 16 (04) : 253 - 263
  • [48] Prognostic value of ZEB-1 in solid tumors: a meta-analysis
    Borong Chen
    Baisheng Chen
    Zhipeng Zhu
    Weipeng Ye
    Junjie Zeng
    Gang Liu
    Shengjie Wang
    Jin Gao
    Guoxing Xu
    Zhengjie Huang
    BMC Cancer, 19
  • [49] Prognostic Value of Transglutaminase 2 in Patients with Solid Tumors: A Meta-analysis
    Gao, Jie
    Wang, Shengjiang
    Wan, Haiyan
    Lan, Jinfeng
    Yan, Yong
    Yin, Dongmei
    Zhou, Wenjing
    Hun, Shouyong
    He, Qi
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2023, 27 (02) : 36 - 43
  • [50] Prognostic value of DcR3 in solid tumors: A meta-analysis
    Ge, Hua
    Liang, Chaojie
    Ren, Shulin
    Yue, Chaosen
    Wu, Jixiang
    CLINICA CHIMICA ACTA, 2018, 481 : 126 - 131